Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia

Leukemia Research

Volumn 29, Issue 5, 2005, Pages 511-515

  Kumagai, Takashi ^a,c   Tefferi, Ayalew ^b   Jones, Letetia ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c Ohme Municipal General Hospital   (Japan)

Author keywords

Cell cycle; Methylation; Myelofibrosis with myeloid metaplasia

Indexed keywords

ARTICLE; CANCER; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; METHYLATION; MYELOFIBROSIS; MYELOID METAPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 14744274735     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.11.002     Document Type: Article

References (51)

1. A. Tefferi Myelofibrosis with myeloid metaplasia New Engl J Med 342 2000 1255 1265
2. J.E. Anderson, G. Sale, F.R. Appelbaum, T.R. Chauncey, and R. Storb Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis Br J Haematol 98 1997 1010 1016
3. F. Cervantes, A. Pereira, J. Esteve, F. Cobo, C. Rozman, and E. Montserrat The changing profile of idiopathic myelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades Eur J Haematol 60 1998 101 105
4. M.C. Martyre, N. Romquin, M.C. Le Bousse-Kerdiles, S. Chevillard, B. Benyahia, and B. Dupriez Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis Br J Haematol 88 1994 9 16
5. R.A. Mesa, C.A. Hanson, S.V. Rajkumar, G. Schroeder, and A. Tefferi Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia Blood 96 2000 3374 3380
6. T. Ueki, M. Toyota, T. Sohn, C.J. Yeo, J.P. Issa, and R.H. Hruban Hypermethylation of multiple genes in pancreatic adenocarcinoma Cancer Res 60 1 2000 1835 1839
7. C. Salem, G. Liang, Y.C. Tsai, J. Coulter, M.A. Knowles, and A.C. Feng Progressive increases in de novo methylation of CpG islands in bladder cancer Cancer Res 60 1 2000 2473 2476
8. J.R. Melki, P.C. Vincent, and S.J. Clark Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia Cancer Res 59 1999 3730 3740
9. S. Baylin, and T.H. Bestor Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1 2002 299 305
10. M. Esteller, and J.G. Herman Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours J Pathol 196 2002 1 7
11. P.A. Jones DNA methylation and cancer Oncogene 21 2002 5358 5360
12. P. Wijermans, M. Lubbert, G. Verhoef, A. Bosly, C. Ravoet, and M. Andre Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients J Clin Oncol 18 2000 956 962
13. M. Wilhelm, S. O'Brien, M.B. Rios, E. Estey, M.J. Keating, and W. Plunkett Phase I study of arabinosyl-5-azacytidine (fazarabine) in adult acute ic myelogenous leukemia in blastic phase Leuk Lymphoma 34 1999 511 518
14. J. Lukas, D. Parry, L. Aagaard, D.J. Mann, J. Bartkova, and M. Strauss Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature 375 1995 503 506
15. J. Koh, G.H. Enders, B.D. Dynlacht, and E. Harlow Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition Nature 375 1995 506 510
16. M. Serrano, G.J. Hannon, and D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 1993 704 707
17. G.J. Hannon, and D. Beach p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest Nature 371 1994 257 261
18. D.J. Simpson, N.A. Hibberts, A.M. McNicol, R.N. Clayton, and W.E. Farrell Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island Cancer Res 60 2000 1211 1216
19. A. Merlo, J.G. Herman, L. Mao, D.J. Lee, E. Gabrielson, and P.C. Burger 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 1995 686 692
20. J.F. Costello, M.S. Berger, H.S. Huang, and W.K. Cavenee Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation Cancer Res 56 1996 240510
21. M. Esteller, S. Tortola, M. Toyota, G. Capella, M.A. Peinado, and S.B. Baylin Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status Cancer Res 60 2000 129 133
22. C. Stirzaker, D.S. Millar, C.L. Paul, P.M. Warnecke, J. Harrison, and P.C. Vincent Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors Cancer Res 57 1997 2229 2237
23. T. Sakai, J. Toguchida, N. Ohtani, D.W. Yandell, J.M. Rapaport, and T.P. Dryja Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene Am J Hum Genet 48 1991 880 888
24. N. Ohtani-Fujita, T.P. Dryja, J.M. Rapaport, T. Fujita, S. Matsumura, and K. Ozasa Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma Cancer Genet Cytogenet 98 1997 43 49
25. E.E. Schmidt, K. Ichimura, K.R. Messerle, H.M. Goike, and V.P. Collins Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours Br J Cancer 75 1997 2 8
26. T. Watanabe, M. Nakamura, Y. Yonekawa, P. Kleihues, and H. Ohgaki Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas Acta Neuropathol (Berl) 101 2001 185 189
27. K.D. Robertson, and P.A. Jones The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53 Mol Cell Biol 18 1998 6457 6473
28. M. Nakamura, T. Watanabe, U. Klangby, C. Asker, K. Wiman, and Y. Yonekawa p14ARF deletion and methylation in genetic pathways to glioblastomas Brain Pathol 11 2001 159 168
29. M. Nakamura, T. Sakaki, H. Hashimoto, H. Nakase, E. Ishida, and K. Shimada Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas Cancer Res 61 2001 6335 6339
30. M. Schutte, R.H. Hruban, J. Geradts, R. Maynard, W. Hilgers, and S.K. Rabindran Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 1997 3126 3130
31. G.J. Nuovo, T.W. Plaia, S.A. Belinsky, S.B. Baylin, and J.G. Herman In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis Proc Natl Acad Sci USA 96 1999 12754 12759
32. E. Lerma, M. Esteller, J.G. Herman, and J. Prat Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus Hum Pathol 33 2002 1120 1125
33. O. Kaplan, T. Kushnir, N. Askenazy, T. Knubovets, and G. Navon Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer Cancer Res 57 1997 1452 1459
34. N. Papadopoulos, and A. Lindblom Molecular basis of HNPCC: mutations of MMR genes Hum Mutat 10 1997 89 99
35. J.G. Herman, A. Umar, K. Polyak, J.R. Graff, N. Ahuja, and J.P. Issa Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma Proc Natl Acad Sci USA 95 1998 6870 6875
36. S.M. Powell, G.M. Petersen, A.J. Krush, S. Booker, J. Jen, and F.M. Giardiello Molecular diagnosis of familial adenomatous polyposis New Engl J Med 329 1993 1982 1987
37. H. Nagase, and Y. Nakamura Mutations of the APC (adenomatous polyposis coli) gene Hum Mutat 2 1993 425 434
38. S.J. Laken, N. Papadopoulos, G.M. Petersen, S.B. Gruber, S.R. Hamilton, and F.M. Giardiello Analysis of masked mutations in familial adenomatous polyposis Proc Natl Acad Sci USA 96 1999 2322 2326
39. M. Miyaki, M. Konishi, R. Kikuchi-Yanoshita, M. Enomoto, T. Igari, and K. Tanaka Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors Cancer Res 54 1994 3011 3020
40. D.B. Levy, K.J. Smith, Y. Beazer-Barclay, S.R. Hamilton, B. Vogelstein, and K.W. Kinzler Inactivation of both APC alleles in human and mouse tumors Cancer Res 54 1994 5953 5958
41. P.J. Morin, A.B. Sparks, V. Korinek, N. Barker, H. Clevers, and B. Vogelstein Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 275 1997 1787 1790
42. V. Korinek, N. Barker, P.J. Morin, D. van Wichen, R. de Weger, and K.W. Kinzler Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma Science 275 1997 1784 1787
43. M. Esteller, A. Sparks, M. Toyota, M. Sanchez-Cespedes, G. Capella, and M.A. Peinado Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer Cancer Res 60 2000 4366 4371
44. J.L. Kissil, E. Feinstein, O. Cohen, P.A. Jones, Y.C. Tsai, and M.A. Knowles DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene Oncogene 15 1997 403 407
45. J.C. Wang, W. Chen, S. Nallusamy, C. Chen, and A.D. Novetsky Hypermethylation of the P15INK4b and P16INK4a in agnogenic myeloid metaplasia (AMM) and AMM in leukaemic transformation Br J Haematol 116 2002 582 586
46. T. Ruutu, S. Partanen, and S. Knuutila Clonal karyotype abnormalities in erythroid and granulocyte-monocyte precursors in polycythaemia vera and myelofibrosis Scand J Haematol 31 1983 253 256
47. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 1996 9821 9826
48. M. Esteller, M. Sanchez-Cespedes, R. Rosell, D. Sidransky, S.B. Baylin, and J.G. Herman Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients Cancer Res 59 1999 67 (Erratum in: Cancer Res 1999;59:3853)
49. D. Yin, D. Xie, W.K. Hofmann, C.W. Miller, K.L. Black, and H.P. Koeffler Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors Oncogene 21 2002 8372 8378
50. J.T. Reilly, G. Wilson, D. Barnett, A. Watmore, and A. Potter Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis Br J Haematol 88 1994 575 581
51. G. Gaidano, A. Guerrasio, A. Serra, F. Carozzi, G.R. Cambrin, and D. Petroni Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders Leukemia 7 1993 946 953